Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable ...

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which ...

The shares are up more than 13% this year, and the pharmaceutical company has several other factors that could drive its ...

CVS Health does a 180. On May 28, CVS Caremark, the pharmacy benefits manager (PBM) under CVS Health's umbrella, announced it ...

Eli Lilly knows that its GLP-1 windfall comes with an end date, so it is acting now to prepare.

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy now for long term growth. Eli Lilly and Company (NYSE:LLY) ...

Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not ...

Lilly’s deal with Ascidian is one of several that the pharma giant has cut within the realm of genetic medicines.

TheFly reported on May 26 that LLY agreed to acquire Vaccine Company, Inc., a clinical-stage biotech focused on in vivo ...

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...

Macro strategist Jordi Visser delivered a striking observation on a recent episode of The Pomp Podcast with Anthony Pompliano ...

The acquisition of Curevo Vaccine, which develops vaccines for shingles and chickenpox, was announced Tuesday.